Overview

Study Evaluating Changes in Total Drug Load and Seizure Frequency Using Vimpat® (Lacosamide) in Combination Therapy

Status:
Completed
Trial end date:
2015-07-01
Target enrollment:
Participant gender:
Summary
This observational study aims to investigate how VIMPAT® is used as adjunctive therapy in clinical practice and will also evaluate the subsequent change in the drug load of patients after addition of VIMPAT® to their treatment regimen.
Details
Lead Sponsor:
UCB Pharma GmbH
Treatments:
Anticonvulsants
Lacosamide